Bio-Rad Laboratories SELL Short-Term Momentum (< 3 Months)Bio-Rad Laboratories shows potential for a SELL based on short-term momentum. Target price is 255.00 USD. Time horizon for this trade is up to 3 months.Shortby AssetfactsPublished 0
BIO: some upside potential?A price action above 340 supports a bullish trend direction. Bullish confirmation for a break above 354.00. The target price is set at 397.00. The stop-loss price is set at 322 (its 50% Fibonacci retracement level). Breaking above its 200-day might trigger further upside potential. Remains a risky trade. Longby Peet_SerfonteinPublished 1
BIO: some upside?A price action above 448 supports a bullish trend direction. The stock is testing its 200-day simple moving average. A change in sentiment towards bullish might occur. Further bullish confirmation for a break above 478. Profit target is at 498. Stop-loss is at 443. Type of a broadening top pattern is busy unfolding. The upper range is highlighted by the 200-week simple moving average.Longby Peet_SerfonteinPublished 1
BIO: some waterfall price action?A price action below 460 supports a bearish trend direction. The stock is testing its 200-day simple moving average. A confirmed cross below this level will change the sentiment to a full-blown bearish sentiment. Increase short exposure for a break below 450. The target price is set at 420. Stop-loss at 490. Negate the bearish stance for a break above 460. The waterfall price effect in stocks refers to a sharp and significant drop in the price of a stock due to a large sell-off by institutional investors or traders. The term "waterfall" is used to describe the downward movement of the stock price, which looks like a waterfall on a price chart. Shortby Peet_SerfonteinPublished 1
BIO | Medical Device Co | Good EntryBio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls for clinical laboratories in the diagnostics market. This segment offers reagents, instruments, and software, which address specific niches within the in vitro diagnostics test market. It sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. In addition, the company offers products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.Longby DivergenceSeekerUpdated 0
BIO // He must break the enemyHe must break the enemy. Let's look for closure where I specified with X. The targets were determined according to Fibonacci.by aet61Published 0
$BIO with a Bullish outlook following its earnings #Stocks The PEAD projected a Bullish outlook for $BIO after a Positive Under reaction following its earnings release placing the stock in drift A with an expected accuracy of 90%. Longby EPSMomentumPublished 0
$BIO - Is in a neutral pH today.$BIO had the bears winning for the last year, but looks like Bulls are starting to pile up and a tag of war is on the verge. NYSE:BIOby wired_maxPublished 0
$BIO with a Neutral outlook following its earnings #Stocks The PEAD projected a Neutral outlook for $BIO after a Positive over reaction following its earnings release placing the stock in drift B with an expected accuracy of 33.33%. by EPSMomentumPublished 0
BIO long scenarioWe are finishing 1 to 5 Elliot wave theory and expecting price to bounce around 450$ zone. Entry: 450 (institutional candle zone) Invalidation 422 (Below buy zone) Target: 644 (top of daily accumulation zone) by vf_investmentPublished 1
Target 1070 ( 1 to 5 months )Up Trend going on, Good Technical and Fundamental so Target 1070, Duration 1 to 5 months...Longby Risk_is_yoursPublished 0
BIO 🌦Although this pattern looks bullish. It might not take call options on it because the beta is low. It might not even be worth my while. Reminder, my trichotomy is comprised of dividend yield < 2%, beta >1 and mkt cap > 15B. Longby MoneymakeroPublished 1
BIO BUY Swing Trading-D1 ascending triangle broken by the top -RSI over 50% -D1 big neutrality zone of RSI -Big bullish trend -Last resistance has been broken Wait that RSI or Price goes back to the green zoneLongby Lauran_ElizaldeUpdated 1
$BIO - one of few undervalued stocksStrong fundamentals. Risks are related to the nature of the business However, as the pandemic folds and healthcare sector accelerates, companies like $BIO, $QDEL, $LH are the ones behind the scenes. Longby game_traderPublished 0
$BIO Big Green Candle on Nice VolCaught by my algo scanner with good PL ratio. Today big green candle on nice volume showing good strength of continuation of upward movement. Its look similar to my NYSE:TMO idea, reference below. Longby fqalogtraderPublished 0
BIO BUY CALL 600 jun18 6000$ 218days cmp: 599 pro: 1.Health BIO BUY CALL 600 jun18 6000$ 218days cmp: 599 pro: 1.Health care sector is a hot sector during covid 2. weekly demand and bouncing in daily as confirmation 3.Aggreessive stock 4.Stock making constantly HH HL in weekly demandLongby financial_freedom_with_gunaPublished 0
Educational Materials nr.5 Net Margin is bigger than Operating Hello dear investors, This article is about rare situation, when net margin is bigger then operating margin. Such situation need to be analyzed well to understanding potential of the company. This happen from external or internal reasons: 1. When company can’t pay taxes and/or have tax benefits. Company will not pay taxes untill she will get net profit as tax benefit. Profit from tax benefit can be holded or payed as dividends. It have good influence on stock growning. In some countries this situation can be because of low or zero taxation. 2. Net profit can be from non-operating activity. It is income from investing activity of the company, selling assets, currency course changing and so on. Company can make her status better in a financial statement. It will seems from big difference between P/E and P/E without NRI. That is mean, that company have most income not from operating activity and is bad signal for investors. Analysis on a BIO case. Net margine is bigger then operating in 8 times. Company has difference between P/E and Price-to-Free-Cash-Flow in 8 times. It means, that declared income does not supported by real result. P/E equality to the P/E without NRI means, that company have income just from operating activity. In this case reason of bigger meaning net margin from operating margin is in taxation. Company does not have cash to pay taxes, so she had tax benefits. She wrote this tax benefits in net income. Cases, when net margin is bigger then operating are rare and need serious research and analysis to understand profitability from investing in this company. Wish you have good investing and big profits, Financial analist and adviser, Valerii SelinEducationby ValueInvest_ProPublished 1
Quick look at BIOnice upward trend, seems like we are in wave 4 for A,B,C pattern, nice entry point at where the green box is. Shortby GodbePublished 2
Bio Rad Laboratories Inc [ NYSE: BIO ]Bio Rad Laboratories Inc Pending Order Placement Entry Placement 450.88 Take Profit Placement 486.31 Stop Loss Placement 427.26by UnknownUnicorn180388Published 52
Biod Rad Laboratories $BIO$BIO just broke the pivot but RSI is still below the trend. It may stall on nextweek.by TheBullseyePublished 4
BIO LONG TRADEBIO has formed a bullish pinbar at the 100 EMA which has previously acted as support, so I would expect the price to bounce off this level BIO is also a fundamentaly good company, and the coronavirus hasn't really affected it as much as the overall stock market, so if we should go long in a stock, BIO could be a potentially good trade Because of the high volatility that we see in the market right now, our SL range should be pretty wide and i will only take the trade if price moves above the pinbar Also my postions size will be smaller because of the volatility Risk to reward = 1/2Longby JonasBuusJPublished 3
ValuEngine upgrades $BIO to a BUY rating ValuEngine Forecast Models 1-Month 346.99 0.51% 3-Month 352.66 2.15% 6-Month 360.17 4.33%Longby ValuEnginePublished 4